Article

Amphetamines detected in exhaled breath from drug addicts: A new possible method for drugs-of-abuse testing.

Department of Medicine, Karolinska Institutet, Stockholm, Sweden. <>
Journal of analytical toxicology (Impact Factor: 2.11). 06/2010; 34(5):233-7.
Source: PubMed

ABSTRACT Testing for drugs of abuse in sample matrices alternative to urine such as blood, sweat, and saliva have received increasing attention and is needed, for example, in traffic medicine. Human breath is known to contain a large number of substances including non-volatile molecules. We explore whether intake of amphetamines could be detected by analytical investigation of exhaled breath from drug addicts. Exhaled breath was collected from 12 drug addict patients after recovering from acute intoxication. Self-reported intake of "amphetamine" was confirmed by analysis of urine and plasma. The compounds were trapped by filtering the air through a modified silica surface and subsequently analyzed by a combined liquid chromatography-tandem mass spectrometry method. As a control, exhaled breath was collected in the same way from eight healthy volunteers. Here we report for the first time that amphetamine and methamphetamine are present in exhaled breath following ingestion of these compounds by drug addicts. Both amphetamine and methamphetamine were indisputably identified by means of the mass spectrometry technique in exhaled breath samples from all 12 patients. Identifications were based on monitoring two product ions in selected reaction monitoring mode and having correct relative ratios (+/- 20%). Excretion rates ranged from 0.2 to 139 pg/min. No amphetamine or methamphetamine was detected in the control subjects. This finding, using a yet non-validated sampling procedure, opens a new possibility for drugs-of-abuse testing. Collection of exhaled breath is likely to be more convenient and safe as compared to matrices presently in use.

0 0
 · 
0 Bookmarks
 · 
128 Views
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Exhaled breath has recently been identified as a matrix for the detection of drugs of abuse. This work aims to further document this application using a new and simple collection device in patients following recovery from acute intoxication. Breath, plasma and urine samples were collected from 47 patients (38 males, age range 25-74) together with interview data. Analysis of breath and plasma samples was done by liquid chromatography-mass spectrometry methods. Urine was screened using immunochemical reagents and positive findings confirmed with liquid chromatography-mass spectrometry methods. The 12 analytes investigated were: methadone, amphetamine, methamphetamine, 6-acetylmorphine, morphine, benzoylecgonine, cocaine, diazepam, oxazepam, alprazolam, buprenorphine and tetrahydrocannabinol. In all 47 cases, recent intake of an abused substance prior to admission was reported, but in one case the substance (ketobemidone) was not investigated. In 40 of the remaining cases (87%) breath analysis gave a positive finding of any of the substances that were part of the analytical investigation. Identifications were based on correct chromatographic retention time and product ion ratios obtained in selected reaction monitoring mode. In general, data from breath, plasma, urine and self-reporting were in good agreement, but in 23% of the cases substances were detected that had not been self-reported. All substances covered were detected in a number of breath samples. Considering that breath sampling was often done about 24 h after intake, the detection rate was considered to be high for most substances. Analytes with low detection rates were benzodiazepines, and a further increase in analytical sensitivity is needed to overcome this. This study further supports use of exhaled breath as a new matrix in clinical toxicology.
    Journal of Breath Research 04/2013; 7(2):026006. · 2.57 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: Within the field of toxicology exhaled breath is used as specimen only for determination of alcohol. However, it was recently discovered that when using sensitive liquid chromatography-mass spectrometry (LC-MS) technique, amphetamine, methamphetamine, and methadone are detectable in exhaled breath following intake by drug addicts. We therefore undertook to develop a method for determination of methadone in exhaled breath condensate from patients undergoing methadonemaintenance treatment. Exhaled breath condensate was collected from 14 patients after intake of the daily methadone dose. The exhaled breath condensate was collected for 10 min using an Ecoscreen instrument. After extraction of any trapped methadone from the condensate by solid-phase extraction, the final extract was analyzed by a combined LC-MS-MS method. Recovery of methadone from breath condensate in the solid-phase extraction was 104%, no significant matrix effects were observed, and the quantification using methadone-d(3) as internal standard was accurate (10% bias) and precise (coefficient of variation 6.2%). Methadone was indisputably identified by means of the MS technique in exhaled breath condensate from all 14 patients. Identification was based on monitoring two product ions in selected reaction monitoring mode with correct relative ratio (± 20%) and correct retention time. Excretion rates ranged from 23.6 to 275 pg/min. No methadone was detected in five control subjects (< 2 pg/min). This finding confirms that methadone is present in exhaled breath from patients in methadone treatment. Collection of exhaled breath specimen is likely to be complementary to other matrices presently in use in testing for drugs-of-abuse.
    Journal of analytical toxicology 01/2011; 35(3):129-33. · 2.11 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Exhaled breath is being developed as a possible specimen for drug testing based on the collection of aerosol particles originating from the lung fluid. The present study was aimed to evaluate the applicability of exhaled breath for drugs of abuse testing in criminal justice settings. Particles in exhaled breath were collected with a new device in parallel with routine urine testing in two Swedish prisons, comprising both genders. Urine screening was performed according to established routines either by dipstick or by immunochemical methods at the Forensic Chemistry Laboratory and confirmations were with mass spectrometry methods. A total of 247 parallel samples were studied. Analysis of exhaled breath samples was done with a sensitive mass spectrometric method and identifications were made according to forensic standards. In addition tested subjects and personnel were asked to fill in a questionnaire concerning their views about drug testing. In 212 cases both the urine and breath testing were negative, and in 22 cases both urine and breath were positive. Out of 6 cases where breath was negative and urine positive 4 concerned THC. Out of 7 cases where, breath was positive and urine negative 6 concerned amphetamine. Detected substances in breath comprised: amphetamine, methamphetamine, THC, methylphenidate, buprenorphine, 6-acetylmorphine, cocaine, benzoylecgonine, diazepam and tramadol. Both the prison inmates and staff members reported breath testing to be preferable due to practical considerations. The results of this study documented that drug testing using exhaled breath provided as many positives as urine testing despite an expected shorter detection window, and that the breath sampling procedure was well accepted and provided practical benefits reported both by the prison inmates and testing personnel.
    Science & Justice 01/2013; · 1.15 Impact Factor

Full-text (2 Sources)

View
1 Download
Available from

O Beck